Syringa pinnata sesquiterpene synthase and application thereof
Through the expression and catalysis of TPS2 protein in feather lilac, the in vitro production of shank sesquiterpene trans neroli tertiary alcohol was achieved, which solved the problem of resource shortage of feather lilac, provided a basis for biosynthesis and improved the supply of medicinal materials.
Patent Information
- Application Number
- CN202110624930.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-06-04
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2041-06-04
AI Technical Summary
The existing technology has failed to effectively synthesize the open-chain sesquiterpene or trans neroli tertiary alcohol of feather leaf lilac, resulting in a shortage of resources for feather leaf lilac and insufficient supply of medicinal materials, and the lack of basic data for related biosynthesis research.
By discovering and using the TPS2 protein in lilac of feather leaf as the trans neroli tertiary alcohol synthase in agarwood sesquiterpene, the expression and catalyzing in prokaryotic microorganisms was carried out, and the production of trans neroli tertiary alcohol in vitro was achieved. method.
It fills the gap in the biosynthesis of sesquiterpenes in the feather leaf lilac, provides a basis for the in vitro production of sesquiterpenes in sesquiterpenes, has good research and development potential and application prospects, and protects wild feather leaf lilac resources.
Smart Images

Figure BDA0003100618530000061 
Figure BDA0003100618530000062 
Figure BDA0003100618530000063
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biological gene engineering, and in particular relates to a syringa pinnata sesquiterpene synthase and an application thereof. Background Art
[0002] Syringa pinnatifolia Hemsl. is the original plant of the Mongolian medicine mountain agarwood. Its peeled and dried roots, stems and thick branches are used as mountain agarwood medicinal materials. Due to the slow growth of Syringa pinnatifolia and the fragility of ecological resources, wild Syringa pinnatifolia was listed as a rare protected species in the last century. Its resources are in short supply and the supply of medicinal materials is obviously insufficient.
[0003] Chemical studies on Syringa syringae have shown that sesquiterpenoids are important pharmacological components of Aquilaria sinensis and have good activity against myocardial ischemia. Therefore, the use of biosynthetic methods to synthesize sesquiterpenoids in vitro is of great significance to the protection of wild resources of Syringa syringae. At the same time, the study of sesquiterpenoid biosynthesis in Syringa syringae also provides basic data for the molecular mechanism of volatile component synthesis in Syringa spp. However, no research related to the biosynthesis of sesquiterpenoids in Syringa syringae has been reported.
[0004] Trans-nerolidol sesquiterpenes have a soft floral aroma and are naturally present in the volatile oils of aromatic plants (such as Eugenia syringae). They can be used as flavoring agents and perfumes, and can also be used to prepare rose-type and lilac-type flavors, with good fixative effects. In addition, trans-nerolidol can also be used as an additive for detergents and cleaning agents. At the same time, studies have also found that trans-nerolidol has rich pharmacological activities, such as antioxidant, antifungal, anticancer and antimicrobial activities. However, there has been no report on the biosynthesis of trans-nerolidol in Eugenia syringae. Summary of the invention
[0005] The technical problem to be solved by the invention is how to synthesize open-chain sesquiterpenes of Syringa japonica or how to produce trans-nerolidol in vitro.
[0006] In order to solve the above technical problems, the present invention first provides any of the following applications of protein:
[0007] P1. Application of the protein in the production of Aquilaria sinensis sesquiterpenes,
[0008] P2. Application of the protein in the preparation and production of agarwood sesquiterpene products;
[0009] The protein may be the following protein A1), A2), A3) or A4):
[0010] A1) The amino acid sequence is the protein of sequence 1 in the sequence list,
[0011] A2) The amino acid sequence is the protein of sequence 3 in the sequence list,
[0012] A3) a fusion protein obtained by fusing a protein tag at the carboxyl terminal or / and the amino terminal of the protein shown in A1) or A2),
[0013] A4) A protein having the same function as the protein shown in A1) or A2) and having more than 80% identity with the protein shown in A1) or A2) obtained by replacing and / or deleting and / or adding one or more amino acid residues in the amino acid sequence shown in SEQ ID NO: 1 in the sequence list.
[0014] The above protein comes from the fresh stem segment of Syringa chinensis, is composed of 578 amino acid residues, and has a predicted protein molecular weight of approximately 66.42 kDa.
[0015] The above proteins can be artificially synthesized, or their encoding genes can be synthesized first and then expressed biologically.
[0016] In the above proteins, the protein tag refers to a polypeptide or protein that is fused and expressed with the target protein using DNA in vitro recombination technology to facilitate the expression, detection, tracing and / or purification of the target protein. The protein tag can be a Flag tag, a His tag, an MBP tag, an HA tag, a myc tag, a GST tag and / or a SUMO tag, etc.
[0017] In the above-mentioned proteins, identity refers to the identity of the amino acid sequence. The identity of the amino acid sequence can be determined using a homology search site on the Internet, such as the BLAST page on the NCBI homepage website. For example, in Advanced BLAST2.1, by using blastp as a program, setting the Expect value to 10, setting all Filters to OFF, using BLOSUM62 as a Matrix, setting the Gap existence cost, Per residue gap cost and Lambda ratio to 11, 1 and 0.85 (default values) respectively, and searching for the identity of a pair of amino acid sequences, the identity value (%) can be obtained.
[0018] In the above proteins, the above 80% identity or more may be at least 81%, 82%, 85%, 86%, 88%, 90%, 91%, 92%, 95%, 96%, 98%, 99% or 100% identity.
[0019] In order to solve the above technical problems, the present invention also provides the use of a protein as an Aquilaria sinensis sesquiterpene trans-nerolidol synthase or in the preparation of trans-nerolidol. The protein may be the protein described above.
[0020] Any of the following applications of the above-mentioned protein-related biomaterials also fall within the scope of protection of the present invention:
[0021] F1. Application of the biological material in the production of Aquilaria sesquiterpenes,
[0022] F2. Application of the biomaterial in the preparation and production of Aquilaria sesquiterpenoid products;
[0023] The biological material may be any one of the following D1) to D6):
[0024] D1) a nucleic acid molecule encoding the protein described above;
[0025] D2) an expression cassette containing the nucleic acid molecule described in D1);
[0026] D3) a recombinant vector containing the nucleic acid molecule described in D1), or a recombinant vector containing the expression cassette described in D2);
[0027] D4) a recombinant microorganism containing the nucleic acid molecule described in D1), or a recombinant microorganism containing the expression cassette described in D2), or a recombinant microorganism containing the recombinant vector described in D3);
[0028] D5) Nucleic acid molecules that promote or increase the expression of the protein described above;
[0029] D6) An expression cassette, a recombinant vector or a recombinant microorganism containing the nucleic acid molecule described in D5).
[0030] In the above application, the nucleic acid molecule D1) may be a gene encoding the protein shown in d1), d2) or d3) below:
[0031] d1) The coding sequence is a cDNA molecule or a DNA molecule of sequence 2 in the sequence list;
[0032] d2) the nucleotide is a cDNA molecule or a DNA molecule of sequence 4 in the sequence list,
[0033] d3) A cDNA molecule or a DNA molecule that hybridizes with the cDNA or DNA molecule defined in d1) or d2) and encodes a protein having the same function.
[0034] In the above-mentioned biological material, the expression cassette containing nucleic acid molecules described in D2) refers to DNA that can express the above-mentioned protein in a host cell. The expression cassette may also include a single-stranded or double-stranded nucleic acid molecule of all regulatory sequences necessary for the nucleic acid molecule expressing any of the above-mentioned proteins. The regulatory sequence can guide the coding sequence to express any of the above-mentioned proteins in a suitable host cell under its compatible conditions. The regulatory sequence includes, but is not limited to, a leader sequence, a polyadenylation sequence, a propeptide sequence, a promoter, a signal sequence and a transcription terminator. At a minimum, the regulatory sequence should include a promoter and termination signals for transcription and translation. In order to introduce a specific restriction enzyme site of the vector so as to connect the regulatory sequence to the coding region of the nucleic acid sequence encoding the protein, a regulatory sequence with a joint can be provided. The regulatory sequence can be a suitable promoter sequence, that is, a nucleic acid sequence that can be recognized by the host cell expressing the nucleic acid sequence. The promoter sequence contains a transcriptional regulatory sequence that mediates protein expression. The promoter can be any nucleic acid sequence that is transcriptionally active in the selected host cell, including mutant, truncated and hybrid promoters, and can be obtained from genes encoding extracellular or intracellular proteins that are homologous or heterologous to the host cell. The regulatory sequence can also be a suitable transcription termination sequence, i.e., a sequence that can be recognized by the host cell to terminate transcription. The termination sequence can be operably connected to the 3' end of the nucleic acid sequence encoding the protein. Any terminator that can function in the selected host cell can be used in the present invention. The regulatory sequence can also be a suitable leader sequence, i.e., an mRNA non-translated region that is very important for the translation of the host cell. The leader sequence can be operably connected to the 5' end of the nucleic acid sequence encoding the protein. Any leader sequence that can function in the selected host cell can be used in the present invention. The regulatory sequence can also be a signal peptide coding region, which encodes an amino acid sequence connected to the amino terminus of the protein, which can guide the encoded protein into the cell secretory pathway. Signal peptide coding regions that can guide the expressed protein into the secretory pathway of the host cell used can be used in the present invention. It may also be necessary to add a regulatory sequence that can regulate protein expression according to the growth of the host cell. Examples of regulatory systems are those that turn gene expression on or off in response to chemical or physical stimuli, including in the presence of regulatory compounds. Other examples of regulatory sequences are those that allow gene amplification. In these examples, the nucleic acid sequence encoding the protein should be operably linked to the regulatory sequence.
[0035] The present invention also relates to a recombinant expression vector comprising a nucleic acid molecule encoding any of the above-mentioned proteins of the present invention, a promoter, and transcription and translation termination signals. When preparing the expression vector, the nucleic acid molecule encoding any of the above-mentioned proteins can be located in the vector so as to be operably linked to an appropriate expression control sequence. The recombinant expression vector can be any vector (e.g., a plasmid or virus) that is convenient for recombinant DNA manipulation and expression of the nucleic acid sequence. The choice of the vector usually depends on the compatibility of the vector with the host cell into which it will be introduced. The vector can be a linear or closed-circular plasmid. The vector can be an autonomously replicating vector (i.e., a complete structure present outside the chromosome that can be replicated independently of the chromosome), such as a plasmid, an extrachromosomal element, a minichromosome, or an artificial chromosome. The vector can contain any mechanism to ensure self-replication. Alternatively, the vector is a vector that, when introduced into a host cell, will be integrated into the genome and replicated together with the chromosome into which it is integrated. In addition, a single vector or plasmid, or two or more vectors or plasmids that generally contain all the DNA to be introduced into the host cell genome, or a transposon, can be used. The vector contains one or more selection markers that are convenient for selecting transformed cells. A selectable marker is a gene whose product confers resistance to biocides or viruses, resistance to heavy metals, or confers prototrophy to an auxotroph, etc. Examples of bacterial selectable markers are the dal genes of Bacillus subtilis or Bacillus licheniformis, or resistance markers to antibiotics such as ampicillin, kanamycin, chloramphenicol, or tetracycline. The vector contains elements that enable the vector to be stably integrated into the host cell genome, or that ensure that the vector replicates autonomously in the cell independently of the cell genome. In the case of autonomous replication, the vector may also contain an origin of replication that enables the vector to replicate autonomously in the target host cell. The origin of replication may carry a mutation that makes it temperature-sensitive in the host cell (see, e.g., fEhrlich, 1978, Proceedings of the National Academy of Sciences of the United States of America 75:1433). One or more copies of a nucleic acid molecule encoding any of the above proteins of the present invention may be inserted into the host cell to increase the yield of the gene product. The number of copies of the nucleic acid molecule can be increased by inserting at least one additional copy of the nucleic acid molecule into the host cell genome, or inserting an amplifiable selection marker together with the nucleic acid molecule, and selecting cells containing amplified copies of the selectable marker gene and thus the additional copies of the nucleic acid molecule by culturing the cells in the presence of a suitable selection agent. The operations for connecting the above-mentioned elements to construct the recombinant expression vector of the present invention are well known to those skilled in the art (see, for example, Sambrook et al., Molecular Cloning Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989).
[0036] The term "operably linked" is defined herein as a configuration in which a regulatory sequence is appropriately positioned relative to the coding sequence of a DNA sequence such that the regulatory sequence directs the expression of a protein.
[0037] The above-mentioned proteins and / or the above-mentioned biological materials also fall within the protection scope of the present invention.
[0038] In order to solve the above technical problems, the present invention also provides a method for preparing agarwood sesquiterpenoid trans-nerolidol. The method may include the following steps: using the above-mentioned protein as agarwood sesquiterpenoid trans-nerolidol synthase TPS2 to catalyze the substrate farnesyl pyrophosphate ammonium salt FPP to obtain the agarwood sesquiterpenoid trans-nerolidol.
[0039] In order to solve the above technical problems, the present invention also provides a method for preparing agarwood sesquiterpenoid trans-nerolidol synthase. The method may include the following steps: expressing the coding gene of the above protein in a prokaryotic microorganism to obtain the agarwood sesquiterpenoid trans-nerolidol synthase.
[0040] In the method described above, the gene encoding the protein described above is expressed in a prokaryotic microorganism, including introducing the gene encoding the protein described above into a recipient microorganism to obtain a recombinant microorganism expressing the Aquilaria aromatica sesquiterpene trans-nerolidol synthase, culturing the recombinant microorganism to express the Aquilaria aromatica sesquiterpene trans-nerolidol synthase.
[0041] The expression described above may be induced expression. In the method described above, the prokaryotic microorganism may be Escherichia coli.
[0042] Any of the following products containing the above-mentioned protein and / or the above-mentioned biological material also falls within the scope of protection of the present invention:
[0043] H1. Production of Aquilaria sesquiterpenoid products;
[0044] H2, production of products containing trans-nerolidol from mountain agarwood sesquiterpenes;
[0045] H3. Preparation and production of Aquilaria sesquiterpenoid products;
[0046] H4. Production of products of Aquilaria sesquiterpenoid trans-nerolidol synthase.
[0047] The present invention discovered TPS2 protein in the Aquilaria sinensis, and proved that the TPS2 protein is the Aquilaria sinensis sesquiterpenoid trans-nerolidol synthase, which can catalyze the substrate farnesyl pyrophosphate ammonium salt FPP to obtain the Aquilaria sinensis trans-nerolidol synthase type sesquiterpenoid. The present invention fills the research gap of the biosynthesis of the open-chain sesquiterpenoid of the Aquilaria sinensis, provides a basis for the in vitro production of the Aquilaria sinensis sesquiterpenoid, and has good research and development potential and application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0048] Figure 1 This is the RNA electrophoresis diagram of Syringa ulina, where M represents DNA marker and 1-2 represents RNA of Syringa ulina.
[0049] Figure 2 This is the electrophoresis diagram of PCR amplification of the sesquiterpene synthase gene TPS2 of Syringa japonica, where M represents DNA marker and 1-2 is the electrophoresis diagram of PCR amplification of TPS2.
[0050] Figure 3 This is the detection of the induced expression product of the recombinant expression plasmid pMAL-c2x-TPS2 of Syringa syringae. The numerical codes in the figure represent different expression conditions, 1 and 8: induced empty whole bacterial solution, 2 and 9: induced empty supernatant, 3 and 10: induced empty precipitate, 4 and 11: uninduced pMAL-c2x-TPS2 whole bacterial solution, 5 and 12: induced pMAL-c2x-TPS2 whole bacterial solution, 6 and 13: induced pMAL-c2x-TPS2 supernatant, 7 and 14: induced pMAL-c2x-TPS2 precipitate, among which 1 to 7 are cultured at 16℃, and 8 to 14 are cultured at 30℃. The bands marked by arrows are TPS2 protein bands.
[0051] Figure 4 This is the post-peak ion chromatogram of the extracted FPP product catalyzed by the TPS2 protein of Syringa syringae. The red arrow indicates the target product, and the black arrow indicates the substrate. A represents the control graph of pMAL-c2x induced at 16°C without load; B represents the control graph of pMAL-c2x induced at 30°C without load; C represents the ion chromatogram of the catalytic product after TPS2 was induced at 16°C by the recombinant plasmid pMAL-c2x-TPS2; D represents the ion chromatogram of the catalytic product after TPS2 was induced at 30°C by the recombinant plasmid pMAL-c2x-TPS2.
[0052] Figure 5 The mass spectrum and standard mass spectrum of the product of trans-nerolidol catalyzed by TPS2 of Syringa syringae. A: Mass spectrum of crude TPS2 enzyme catalysis product; B: Mass spectrum of standard trans-nerolidol. The horizontal axis is the mass-to-charge ratio (m / z) of the ion, and the vertical axis is the intensity of the ion current. DETAILED DESCRIPTION
[0053] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.
[0054] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.
[0055] Example 1: Prokaryotic expression of Syringa syringae sesquiterpene synthase gene TPS2
[0056] The amino acid sequence of the eremophilene synthase TPS2 is shown as Sequence 1 in the sequence table, and the CDS sequence of the cDNA of TPS2 is shown as the nucleotide sequence of Sequence 2 in the sequence table.
[0057] 1. Construction of pMAL-c2x-TPS2 expression vector
[0058] See Example 3 for the full-length cloning of the Syringa syringae sesquiterpene synthase gene TPS2. The CDS sequence of the TPS2 gene (sequence 2 in the sequence list) was used as a template, and the NEBcutter 2.0 online software was used to analyze and select the restriction sites that exist in the target expression vector but not in the inserted gene, and primers with restriction sites were designed to increase connectors at both ends of the full-length gene. The restriction sites designed for TPS2 are EcoRI and SalI, and the primers used are as follows. The underlined sequence is the restriction site recognition sequence.
[0059]
[0060] The reaction system of TPS2 with adapter gene is as follows:
[0061]
[0062] The PCR procedure for TPS2 is as follows. The PCR product obtained after PCR is the CDS sequence of TPS2 with restriction enzyme recognition sites of EcoRI and SalI:
[0063]
[0064] Vector linearization: The blank pMAL-c2X vector (preserved in this laboratory, the public can obtain it from the applicant to repeat this experiment. Related literature: Su P, et al. Identification and functional characterization of diterpene synthases for triptolide biosynthesis from Tripterygium wilfordii. Plant Journal, 2018, 93: 50-65.) was double-digested to obtain a linearized pMAL-c2X vector. At the same time, the CDS sequence of the TPS2 gene with the added restriction endonuclease recognition site was double-digested with restriction endonucleases EcoRI and SalI to obtain the target gene fragment after double digestion. The digestion system is as follows. The endonucleases used by TPS2 for subsequent connection vectors are EcoRI and SalI, and the digestion conditions are all 37°C digestion for 3h.
[0065]
[0066] Use Uni Seameless Assembly Kit to connect the double-enzyme-cut target gene fragment and the linearized pMAL-c2X vector. React at 50°C for 15 minutes, and cool on ice after the reaction. Finally, the recombinant expression vector pMAL-c2X-TPS2 is obtained. The recombinant expression vector pMAL-c2X-TPS2 replaces the fragment (small fragment) between the EcoRI and SalI recognition sites of pMAL-c2X with the nucleotides 1-1734 of sequence 2 in the sequence list, and keeps the other sequences of pMAL-c2X unchanged to obtain the TPS2 gene recombinant expression vector. The pMAL-c2X-TPS2 recombinant vector contains the recombinant TPS2 gene TPS2-MBP with an MBP tag sequence (sequence 4 in the sequence list), and can express the recombinant TPS2 protein TPS2-MBP with an MBP tag shown in sequence 3 in the sequence list.
[0067] 2. Prokaryotic expression of TPS2 protein
[0068] The recombinant gene expression vector pMAL-c2X-TPS2 was expanded and cultured to extract the plasmid pMAL-c2X-TPS2, and then the recombinant plasmid pMAL-c2X-TPS2 was transformed into expression competent cells, and the cells used for transformation were competent cells of Escherichia coli Transetta (DE3) (Beijing Quanshijin Biotechnology Co., Ltd., CD801-02), to obtain recombinant Escherichia coli DE3 / pMAL-c2x-TPS2. At the same time, the pMAL-c2x empty plasmid was transformed into Transetta (DE3) competent cells to obtain recombinant empty Escherichia coli DE3 / pMAL-c2x.
[0069] The recombinant Escherichia coli DE3 / pMAL-c2x-TPS2 bacterial solution was expanded and cultured at a ratio of 1:50 using LB culture medium containing ampicillin antibiotics. The culture was carried out at 37°C and 200rpm for about 3h, and the OD value at 600nm was measured to be between 0.6 and 1.0, and the uninduced pMAL-c2x-TPS2 whole bacterial solution and the uninduced empty whole bacterial solution were obtained. IPTG was added to the uninduced pMAL-c2x-TPS2 whole bacterial solution and the uninduced empty whole bacterial solution to a final concentration of 500μM, and then cultured overnight (12h) at the same temperature, with the temperature of 16°C and 30°C, and the rotation speed was maintained at 200rpm for induction expression, and the fermentation liquid was collected, and the fermentation liquid obtained by induced expression of recombinant Escherichia coli DE3 / pMAL-c2x-TPS2 was named induced pMAL-c2x-TPS2 whole bacterial solution, and the fermentation liquid obtained by induced expression of recombinant Escherichia coli DE3 / pMAL-c2x was named induced empty whole bacterial solution.
[0070] The whole bacterial solution of induced pMAL-c2x-TPS2 and the whole bacterial solution of induced empty load were centrifuged at 5000rpm for 10min at 4℃, the supernatant was discarded, and the solution was washed again with sterile water and centrifuged to ensure that the culture medium was completely removed. Then 500μL of PBS buffer was added, mixed and ultrasonically broken on ice, ultrasonicated at 30% energy for 3s, paused for 7s, and a total of 10min. After ultrasonication, a part was retained as the whole bacterial solution, and the rest was centrifuged at 12000rpm for 20min at 4℃, and the supernatant was aspirated to obtain the supernatant of induced pMAL-c2X-TPS2 and the supernatant of induced empty load, respectively; the precipitate was added with the same volume of PBS buffer as the supernatant and mixed to obtain the precipitate of induced pMAL-c2X-TPS2 and the precipitate of induced empty load, respectively, and the following SDS-PAGE was performed.
[0071] 3. Polyacrylamide gel electrophoresis (SDS-PAGE)
[0072] First, prepare SDS-PAGE separation gel according to the following formula, add an appropriate amount of separation gel to the clamped glass plate, add water to seal it to prevent drying and make the gel surface smooth; after the separation gel solidifies, remove the water and prepare SDS-PAGE concentrated gel, add it on top of the solidified separation gel, insert a comb, and set it aside after solidification.
[0073] SDS-PAGE separation gel formula
[0074]
[0075] SDS-PAGE stacking gel recipe
[0076]
[0077] Take a portion of the recombinant bacterial solution and the empty bacterial solution obtained in step 2, add SDS-PAGE Buffer, mix well, boil in boiling water for 5 minutes, and then take the solution for sample loading. Run at 80V for 30 minutes, then change to 120V for 1 hour. After taking out the gel, use Coomassie Brilliant Blue R250 dye solution to stain for 2 hours, decolorize for about 4 hours, and take a photo for storage and analysis ( Figure 3 ). The predicted size of TPS2 protein is 66 kDa, and the predicted size of recombinant protein TPS2-MBP is 109 kDa. Figure 3 The results showed that the recombinant protein TPS2-MBP (band size was approximately 100 kDa, close to the predicted value) was detected in the induced pMAL-c2X-TPS2 whole cell solution, induced pMAL-c2X-TPS2 supernatant and induced pMAL-c2X-TPS2 precipitate; while the recombinant protein TPS2-MBP band was not detected in the induced empty cell solution, induced empty supernatant and induced empty precipitate.
[0078] Example 2: Functional verification of the Syringa syringae sesquiterpene synthase gene TPS2
[0079] 1. Enzyme-catalyzed reaction
[0080] The enzymatic reaction system is 400 μL in total, including 282 μL of the induced pMAL-c2X-TPS2 supernatant (referred to as TPS2 crude enzyme) obtained in Example 1, Farnesyl pyrophosphate ammonium salt (FPP) (Sigma-Aldrich, USA, F6892-1VL) as substrate (final concentration 50 μM), HEPES (Sigma-Aldrich, USA, H7006) (Ph7.2) is added to 50 mM, and the rest includes magnesium chloride to 7.5 mM, HEPES (pH7.2) final concentration 50 mM, glycerol 5%, and 5 mM DTT (dithiothreitol) (Promega, USA, V3151). After the above system is mixed, 500 μL of n-hexane is added on top to cover to prevent the volatile sesquiterpene product from escaping, and the reaction is carried out in a water bath at 30°C for 1 hour to obtain the enzymatic reaction catalytic product (TPS2 crude enzyme catalytic product). After the reaction was completed, the mixture was vortexed and centrifuged at 10,000 rpm for 5 minutes, and the upper n-hexane organic phase was taken for component determination. At the same time, the induced empty supernatant in Example 1 was added to the enzymatic reaction system with other substances and the same content as a control to obtain the enzymatic reaction catalytic product.
[0081] 2. Product testing
[0082] The catalytic products of the enzymatic reaction were filtered through a 0.22 μm polytetrafluoroethylene organic filter membrane and then determined using GC-MS. The conditions were an initial temperature of 100°C, maintained for 3.5 min, then raised to 170°C at a rate of 20°C / min, then slowly raised to 180°C at a rate of 0.5°C / min, then raised to 250°C at a rate of 25°C / min, and finally raised to 300°C at a rate of 5°C / min and maintained for 5 min. The injection port temperature was 280°C, the ion source was EI, the electron energy was 70 eV, the ion source temperature was 230°C, and the scanning range was 40-400 m / z. The post-peak ion flow diagrams of the product extractions after FPP was catalyzed by the empty vector bacterial solution and the recombinant bacterial solution containing the recombinant protein TPS2-MBP are shown in Figure 4 , compared with no-load ( Figure 4 A and B), TPS2 enzyme catalyzed the successful acquisition of the target product at 16℃ and 30℃ ( Figure 4 C and D), the catalytic product has a single peak at 9.42min, and the product is relatively simple. Further according to the mass spectrum, it can be seen that the sesquiterpene product ( Figure 5 A) and the mass spectrum of trans-nerolidol ( Figure 5 In B), therefore, the function of the TPS2 encoding enzyme TPS2 is to catalyze the production of trans-nerolidol, and it can be named trans-nerolidol synthase.
[0083] Example 3: Full-length cloning of the Syringa syringae sesquiterpene synthase gene TPS2
[0084] 1. Extraction of RNA from Syringa pinnata
[0085] Add 1mL of Trizol reagent to a 2mL centrifuge tube, then grind the fresh stem sample of Syringa syringae into fine powder under liquid nitrogen, and quickly add it to the centrifuge tube with Trizol reagent, and vortex to mix. Centrifuge at 12000rpm for 10min, and take the supernatant to another centrifuge tube. Add chloroform about 1 / 5 of the supernatant volume to the centrifuge tube, shake vigorously for 15s, leave it at room temperature for 2-3min, and then centrifuge at 12000rpm for 15min. Pipette the upper aqueous phase to another centrifuge tube, add isopropanol half the volume of the aqueous phase to the centrifuge tube, invert and mix, leave it at room temperature for 10min, and then centrifuge at 12000rpm for 10min. After centrifugation, discard the supernatant, and a small amount of white precipitate can be seen at the bottom of the tube. Use 75% ethanol to wash the inner tube cap, tube wall and precipitate of the centrifuge tube, and centrifuge at 12000rpm for 5min, discard the supernatant, and then change the 75% concentration ethanol in the previous step to anhydrous ethanol, and repeat it. Finally, the absolute ethanol was blown dry to prevent the next step from being affected, and the RNA integrity was detected by 1% agarose gel electrophoresis ( Figure 1 ).
[0086] 2. Reverse transcription of Syringa ulina cDNA
[0087] Use a pipette to draw 10 μL of the extracted RNA and add 2 μL of Oligo(dT) 18 , centrifuge and mix, react at 70℃ for 10min, then place on ice for 2min. Then add 4μL of 5×ReverseTranscriptase M-MLV Buffer, 1μL of Recombinant RNase Inhibitor, 2μL of dNTP, 1μL of Reverse Transcriptase M-MLV (RNase H-) to the solution obtained in the previous step, react at 42℃ for 60min, keep at 70℃ for 15min, and finally store the obtained cDNA in a -20℃ refrigerator.
[0088] 3. Cloning of the full-length sequence of Syringa ulina TPS2
[0089] (1) Primers used for full-length cloning of TPS2 are:
[0090] Upstream primer: 5'-ACGTCTTCTAATTAATAAGCATAGTTCTTTATCTCA-3' Downstream primer: 5'-ACAGATTTCGCTGCATCTAGTCA-3'
[0091] (2) The reaction system used for TPS2 full-length cloning is:
[0092]
[0093] (3) The PCR reaction procedure used for TPS2 full-length cloning is:
[0094]
[0095]
[0096] The PCR product was detected by agarose gel electrophoresis, and the target PCR product band of about 1600 to 1700 bp was recovered by gel extraction using a kit Thermo Scientific GeneJET Gel Extraction Kit to obtain a purified product, i.e., the full-length sequence (CDS) of the purified TPS2 gene (sequence 2 in the sequence list), and its translated protein sequence is (sequence 1 in the sequence list).
[0097] (4) Vector ligation and transformation
[0098] Use pEASY-Blunt Zero Cloning Kit (Beijing Quanshijin Biotechnology Co., Ltd., CU101) for vector connection. Take 4 μL of CDS of TPS2 gene purified in step (3), add 1 μL of pEASY-Blunt ZeroCloning Vector, mix gently and react at room temperature for 30 minutes to obtain the connection product of TPS2 and cloning vector, then place the centrifuge tube on ice. Thaw Escherichia coli Trans1-T1 competent cells (Beijing Quanshijin Biotechnology Co., Ltd., CD501) on ice in advance, and place the centrifuge tube on ice to cool down. When the competent cells are just thawed, quickly divide them into 50 μL per tube, and add the connection product of TPS2 and cloning vector in the previous step to the competent cells, mix well, and place them on ice for 30 minutes, then heat shock them in a 42℃ water bath for 30 seconds, and immediately place them on ice for 2 minutes. Then, add 450 μL of liquid LB medium without ampicillin to the product after transformation into cells, and culture it in a shaker at 200 rpm and 37°C for 1 hour. After taking it out, centrifuge it at 2000 rpm for 4 minutes, aspirate 300 μL of the supernatant medium, mix the rest and spread it on the LB solid medium containing ampicillin, and culture it at 37°C overnight.
[0099] (5) Monoclonal culture and verification
[0100] The monoclonal colonies grown on the culture medium cultured overnight in step (4) were picked and cultured in 1 ml of LB culture medium containing ampicillin at 200 rpm and 37°C for 6 h. 1 μL of the bacterial solution was taken for PCR verification. The system was as follows:
[0101]
[0102] Bacterial liquid PCR reaction procedure:
[0103]
[0104]
[0105] After confirming that the PCR product of the bacterial solution is the target size band, Sanger sequencing is performed to finally obtain a positive monoclonal colony containing the TPS2 gene vector. The agarose gel electrophoresis of the PCR product of the positive monoclonal colony is shown in Figure 2 The sequencing results showed that the positive monoclonal bacterial solution contained the full length of sequence 2 in the sequence list, i.e., the CDS sequence of the gene encoding the eremophilene synthase TPS2 from Aquilaria sinensis, and the amino acid sequence of the corresponding eremophilene synthase TPS2 protein from Aquilaria sinensis was as shown in sequence 1 in the sequence list. The predicted size of the TPS2 protein was 66 kDa.
[0106] The present invention has been described in detail above. It will be apparent to those skilled in the art that the present invention may be implemented in a wide range under equivalent parameters, concentrations and conditions without departing from the spirit and scope of the present invention and without the need for unnecessary experimentation. Although the present invention provides specific embodiments, it should be understood that further improvements may be made to the present invention. In short, according to the principles of the present invention, this application intends to include any changes, uses or improvements to the present invention, including changes made by conventional techniques known in the art that depart from the scope disclosed in this application. Applications of some of the basic features may be made within the scope of the following appended claims. Sequence Listing <110> Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences <120> Syringa pinnata sesquiterpene synthase and application thereof <130> GNCSQ211359 <160> 4 <170> PatentIn version 3.5 <210> 1 <211> 578 <212> PRT <213> Syringa pinnatifolia Hemsl. (Syringa pinnatifolia Hemsl.) <400> 1 Met Ala Val Tyr Lys Thr Phe Ser Ser Leu Pro Ser Gln Cys Tyr Ile 1 5 10 15 His Thr Lys Ile Ala Asp Asn Gly Asp Arg Arg Pro Ser Leu Val Ala 20 25 30 Cys Arg Ala Thr Pro Gln Lys Trp Thr Ile Leu Glu Ala Thr Ser Asp 35 40 45 Leu Ser Lys Pro His Gln Ile Ile Gln Asn Gly Gln Ser Phe Lys Asp 50 55 60 Glu Phe Ser Met Glu Tyr Asp Gln Ile Leu Lys His Val Arg Glu Leu 65 70 75 80 Leu Lys Ser Gly Lys Phe Glu Asn Pro Thr Glu Ser Leu Met Leu Val 85 90 95 Asp Ser Ile Gln Arg Leu Gly Ile Glu Tyr His Phe Gln Glu Glu Ile 100 105 110 Glu Ala Val Leu Arg Arg His Tyr Met Glu Ala Thr Thr Cys Phe Asp 115 120 125 Val His Ser Asp Tyr Thr Leu His Asp Leu Ser Leu Phe Phe Arg Leu 130 135 140 Leu Arg Gln His Gly Phe Phe Ile Pro Ala Asp Ile Phe Asn Asn Phe 145 150 155 160 Lys Gly Lys Asp Gly Met Phe Glu Glu Lys Leu Thr Gln Asp Ile Arg 165 170 175 Gly Leu Met Glu Leu Cys Glu Ala Ala Gln Leu Val Thr Glu Gly Glu 180 185 190 Asp Ile Leu Asp Glu Ala Ala Lys Phe Ser Ser Gln Phe Val Ser Asn 195 200 205 Arg Leu Lys His Pro Tyr His Lys Ser Ile Ala Arg Phe Thr Ala Lys 210 215 220 Asn Tyr Ile Arg Asp Phe Gln Gly Ile Asn Ile Gly Trp Glu Lys Thr 225 230 235 240 Leu Lys Glu Leu Ala Lys Met Asp Phe Ser Leu Ala Gln Thr Ala Asn 245 250 255 Gln Gln Glu Leu Ala Gln Ile Ser Lys Trp Trp Lys Asp Leu Gly Leu 260 265 270 Ala Gln Glu Phe Lys His Ala Arg Asn Gln Pro Leu Lys Trp Tyr Thr 275 280 285 Trp Ser Met Ala Ser Leu Ser Asp Pro Ser Met Ser Glu Gln Arg Leu 290 295 300 Glu Leu Thr Lys Ser Ile Thr Phe Ile Tyr Ile Ile Asp Asp Ile Phe 305 310 315 320 Asp Leu Tyr Gly Thr Pro Glu Asp Leu Thr Val Phe Thr Gln Ala Val 325 330 335 His Arg Trp Asp Tyr Ala Ala Val Asp Met Leu Pro Lys Pro Trp Lys 340 345 350 Met Cys Tyr Lys Ala Leu Leu Asp Thr Thr Asn Asp Ile Gly Ser Lys 355 360 365 Ile Tyr Lys Met His Gly Tyr Asn Pro Ile Asp Ser Leu Lys Ser Thr 370 375 380 Trp Ala Ser Leu Cys Asp Ala Phe Leu Val Glu Ala Lys Trp Phe Ala 385 390 395 400 Ser Gly His Leu Pro Thr Thr His Glu Tyr Leu Glu Asn Gly Lys Val 405 410 415 Ser Ser Gly Val His Val Val Leu Val His Leu Phe Phe Leu Leu Gly 420 425 430 Ile Asn Gly Gly Thr Val Gln Val Asp Asp Ile Ser Ala Leu Ile Ser 435 440 445 Ser Val Ala Ala Ile Leu Arg Leu Trp Asp Asp Phe Gly Ser Ala Lys 450 455 460 Asp Glu Gln Gln Asp Gly Asp Gly Ser Tyr With Glu Cys Tyr Met 465 470 475 480 Lys Glu Asn Pro Gly Ser Thr Val Glu Ile Ala Arg Asp Arg Val Val 485,490,495 Asp With Ser Glu Trp Lys Arg Leu Asn Lys Glu Cys Phe Arg 500 505 510 Leu Asn Gln Pro Asn Ser Ser Ser Phe Thr Lys Ala Ser Phe Asn 515,520,525 Leu Ala Arg Met Val Pro Leu Met Tyr Ser Tyr Asp Asp Asn Gln Gln 530 535 540 Leu Pro Val Leu Glu Glu Tyr Ile Asn Ser Thr Leu Phe Asp Asp Asn 545 550 555 560 Phe Leu Val His Pro Ala Gln Leu Met Lys Asn Ala Thr Ile Arg 565,570,575 Gly Ser <210> 2 <211> 1737 <212> DNA <213> Artificial Sequence <400> 2 atggcagtct acagacctt ctcgtcctta cccagccagt gttatattca tacaaaaatt 60 gcagataatg gagataggag accatctctt gttgcatgta gagctactcc tcagaaatgg 120 accattcttg aagcaacttc tgaccctct aaaccacatc aaatcattca gatggacag 180 agttttaagg atgaatttc steps gaccaatc tgagcatgt steps 240 ttgaaatcag ggaaattcga aaatccaaca gaaagcttaa tgttggtgga ttctatacag 300 cgactcggta ttgaatacca ttttcaggaa gagattgaag cagttcttcg gcgacattac 360 atggaagcca ccacttgttt tgatgtgcac tcggattaca ctctcacga tcttcactt 420 ttcttcagac tcttgagaca acatggtttt ttcattcccg cagacatatt cacaacttc 480 aaggaaag atgggtt tgagagaaa ttacgcaag attcagagg attgagaa 540 ttgtgtgaag ctgctcaact agtgacagaa ggagaata ttctgatga agcagcaaaa 600 tttagtagcc aatttgttag taacagattg aaacatcctt atcacaaag cattgcaaga 660 tttactgcga aaactatat tagagatttc CAggcataa atattgtg ggaaaaaaca 720 ttgaaagagc tcgccaaaat ggatttttcc ttggcacaga ccgccaatca acagaactt 780 gcccaaattt ccaagtggtg gaaagacctt ggcttggctc aggagtttaa gcatgctagg 840 aatcaacctt taaaatggta tacatggtcc atggcctccc taagtgatcc aagcatgtct 900 gagcaaagac ttgagctcac caaatccatc acatttattt acataataga tgacattttt 960 gatctttatg ggaccccaga agaccttact gtctttatc aagctgtaca caggtgggac 1020 tatgcagccg ttgacatgtt accaaaacct tggaagatgt gttacaaggc tcttcttgac 1080 accacaaatg atataggcag caagatctac aaaatgcacg gatataatcc catcgattct 1140 ctaaaatcaa catgggcaag tctgtgtgac gcattcctag tagaagctaa atggtttgct 1200 tcagggcact tgccaaccac ccatgagtac ctagaaaatg gtaaggtgag ttcaggagta 1260 catgtggtgc tcgtccacct cttctttctt ttgggaatca atgggggac cgttcaggtg 1320 gatgatattt cagcactcat atcctctgtg gctgctattc tccgtctctg ggatgacttt 1380 ggaagtgcta aggatgagca gcaagatgga aacgatggtt cgtacatag gtgctacatg 1440 aaagaaaatc caggatcaac cgttgagatt gcacgagatc gtgttgttga tatgatatca 1500 agtgaatgga agcggcttta caaggtgt ttcgtttaa atcaaatcc atcaagttca 1560 tctttcacaa aagctcttt taatcttgca agaatggtcc ctctaatgta cagttacgat 1620 guckaccaac agctcccagt acttgagag tacatcaac ccacactt tgatgataat 1680 ttcttggtgc accatccagc acactgatg aagaatgcca caatcgtgg gtcatag 1737 <210> 3 <211> 969 <212> PRT <213> Artificial Sequence <400> 3 Met Lys Ile Glu Glu Gly Lys Leu Val Ile Trp Ile Asn Gly Asp Lys 1 5 10 15 Gly Tyr Asn Gly Leu Ala Glu Val Gly Lys Phe Glu Lys Asp Thr 20 25 30 Gly Ile Lys Val Thr Val Glu His Pro Asp Lys Leu Glu Glu Lys Phe 35 40 45 Pro Gln Val Ala Ala Thr Gly Asp Gly Pro Asp Ile Ile Phe Trp Ala 50 55 60 His Asp Arg Phe Gly Gly Tyr Ala Gln Ser Gly Leu Leu Ala Glu Ile 65 70 75 80 Thr Pro Asp Lys Ala Phe Gln Asp Lys Leu Tyr Pro Phe Thr Trp Asp 85 90 95 Ala Val Arg Tyr Asn Gly Lys Leu Ile Ala Tyr Pro Ile Ala Val Glu 100 105 110 Ala Leu Ser Leu Ile Tyr Asn Lys Asp Leu Leu Pro Asn Pro Pro Lys 115 120 125 Thr Trp Glu Glu Ile Pro Ala Leu Asp Lys Glu Leu Lys Ala Lys Gly 130 135 140 Lys Ser Ala Leu Met Phe Asn Leu Gln Glu Pro Tyr Phe Thr Trp Pro 145 150 155 160 Leu Ile Ala Ala Asp Gly Gly Tyr Ala Phe Lys Tyr Glu Asn Gly Lys 165 170 175 Tyr Asp Ile Lys Asp Val Gly Val Asp Asn Ala Gly Ala Lys Ala Gly 180 185 190 Leu Thr Phe Leu Val Asp Leu Ile Lys Asn Lys His Met Asn Ala Asp 195 200 205 Thr Asp Tyr Ser Ile Ala Glu Ala Ala Phe Asn Lys Gly Glu Thr Ala 210 215 220 Met Thr Ile Asn Gly Pro Trp Ala Trp Ser Asn Ile Asp Thr Ser Lys 225 230 235 240 Val Asn Tyr Gly Val Thr Val Leu Pro Thr Phe Lys Gly Gln Pro Ser 245 250 255 Lys Pro Phe Val Gly Val Leu Ser Ala Gly Ile Asn Ala Ala Ser Pro 260 265 270 Asn Lys Glu Leu Ala Lys Glu Phe Leu Glu Asn Tyr Leu Leu Thr Asp 275 280 285 Glu Gly Leu Glu Ala Val Asn Lys Asp Lys Pro Leu Gly Ala Val Ala 290 295 300 Leu Lys Ser Tyr Glu Glu Glu Leu Ala Lys Asp Pro Arg Ile Ala Ala 305 310 315 320 Thr Met Glu Asn Ala Gln Lys Gly Glu Ile Met Pro Asn Ile Pro Gln 325 330 335 Met Ser Ala Phe Trp Tyr Ala Val Arg Thr Ala Val Ile Asn Ala Ala 340 345 350 Ser Gly Arg Gln Thr Val Asp Glu Ala Leu Lys Asp Ala Gln Thr Asn 355 360 365 Ser Ser Ser Asn Asn Asn Asn Asn Asn Asn Asn Asn Leo Gly Ile 370 375 380 Glu Gly Arg Ile Ser Glu Phe Met Ala Val Tyr Lys Thr Phe Ser Ser 385 390 395 400 Leu Pro Ser Gln Cys Tyr Ile His Thr Lys Ile Ala Asp Asn Gly Asp 405 410 415 Arg Arg Pro Ser Leu Val Ala Cys Arg Ala Thr Pro Gln Lys Trp Thr 420 425 430 Ile Leu Glu Ala Thr Ser Asp Leu Ser Lys Pro His Gln Ile Ile Gln 435 440 445 Asn Gly Gln Ser Phe Lys Asp Glu Phe Ser Met Glu Tyr Asp Gln Ile 450 455 460 Leu Lys His Val Arg Glu Leu Leu Lys Ser Gly Lys Phe Glu Asn Pro 465 470 475 480 Thr Glu Ser Leu Met Leu Val Asp Ser Ile Gln Arg Leu Gly Ile Glu 485 490 495 Tyr His Phe Gln Glu Glu Ile Glu Ala Val Leu Arg Arg His Tyr Met 500 505 510 Glu Ala Thr Thr Cys Phe Asp Val His Ser Asp Tyr Thr Leu His Asp 515 520 525 Leu Ser Leu Phe Phe Arg Leu Leu Arg Gln His Gly Phe Phe Ile Pro 530 535 540 Ala Asp Ile Phe Asn Asn Phe Lys Gly Lys Asp Gly Met Phe Glu Glu 545 550 555 560 Lys Leu Thr Gln Asp Ile Arg Gly Leu Met Glu Leu Cys Glu Ala Ala 565 570 575 Gln Leu Val Thr Glu Gly Glu Asp Ile Leu Asp Glu Ala Ala Lys Phe 580 585 590 Ser Ser Gln Phe Val Ser Asn Arg Leu Lys His Pro Tyr His Lys Ser 595 600 605 Ile Ala Arg Phe Thr Ala Lys Asn Tyr Ile Arg Asp Phe Gln Gly Ile 610 615 620 Asn Ile Gly Trp Glu Lys Thr Leu Lys Glu Leu Ala Lys Met Asp Phe 625 630 635 640 Ser Leu Ala Gln Thr Ala Asn Gln Gln Glu Leu Ala Gln Ile Ser Lys 645 650 655 Trp Trp Lys Asp Leu Gly Leu Ala Gln Glu Phe Lys His Ala Arg Asn 660 665 670 Gln Pro Leu Lys Trp Tyr Thr Trp Ser Met Ala Ser Leu Ser Asp Pro 675 680 685 Ser Met Ser Glu Gln Arg Leu Glu Leu Thr Lys Ser Ile Thr Phe Ile 690 695 700 Tyr Ile Ile Asp Asp Ile Phe Asp Leu Tyr Gly Thr Pro Glu Asp Leu 705 710 715 720 Thr Val Phe Thr Gln Ala Val His Arg Trp Asp Tyr Ala Ala Val Asp 725 730 735 Met Leu Pro Lys Pro Trp Lys Met Cys Tyr Lys Ala Leu Leu Asp Thr 740 745 750 Thr Asn Asp Ile Gly Ser Lys Ile Tyr Lys Met His Gly Tyr Asn Pro 755 760 765 Ile Asp Ser Leu Lys Ser Thr Trp Ala Ser Leu Cys Asp Ala Phe Leu 770 775 780 Val Glu Ala Lys Trp Phe Ala Ser Gly His Leu Pro Thr Thr His Glu 785 790 795 800 Tyr Leu Glu Asn Gly Lys Val Ser Ser Gly Val His Val Val Leu Val 805 810 815 His Leu Phe Phe Leu Leu Gly Ile Asn Gly Gly Thr Val Gln Val Asp 820 825 830 Asp Ile Ser Ala Leu Ile Ser Ser Val Ala Ala Ile Leu Arg Leu Trp 835 840 845 Asp Asp Phe Gly Ser Ala Lys Asp Glu Gln Gln Asp Gly Asn Asp Gly 850 855 860 Ser Tyr Ile Glu Cys Tyr Met Lys Glu Asn Pro Gly Ser Thr Val Glu 865 870 875 880 Only Arg Asp Arg Val Val Asp With Only Served On Glu Trp Lys Arg 885,890,895 Leu Asn Lys Glu Cys Phe Arg Leu Asn Gln Asn Pro Ser Ser Ser Ser 900 905 910 Phe Thr Lys Ala Ser Phe Asn Leu Ala Arg Met Val Pro Leu Met Tyr 915,920,925 Ser Tyr Asp Asp Asn Gln Gln Lew Pro Val Lew Glu Glu Tyr Ile Asn 930,935,940 Ser Thr Leu Phe Asp Asp Asn Phe Leu Val His His Pro Ala Gln Leu 945 950 955 960 Met Lys Asn Ala Thr Ile Arg Gly Ser 965 <210> 4 <211> 2910 <212> DNA <213> Artificial Sequence <400> 4 atgaaaatcg aagaaggtaa actgtaatc tggattaacg gcgataaagg ctataacggt 60 ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaagtcac cgttgagcat 120 ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180 atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240 accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300 aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360 gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420 aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480 ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540 gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600 aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660 ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720 gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780 ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840 ctcgaaaact atctgctgac tgatgaggt ctggaagcgg ttaataaga caaccgctg 900 ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960 actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020 tggtatgccg tgcgtactgc gtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080 gccctgaaag acgcgcagac taattcgagc tcgaaca acaata caatacaac 1140 aacctcggga tcgagggaag gatttcaga ttcatggcag tctacagac cttctcgtcc 1200 ttacccagcc agtgttatat tcatacaaaa attgcagata atggagatag gagaccatct 1260 cttgttgcat gtagagctac tcctcagaaa tggaccattc ttgagcac ttctgacctc 1320 tctaaaccac atcaatcat tcagaatgga cagagtttta aggatgat tccatgga 1380 tatgaccaaa tactgaagca tgtcagga ttattgaat cagggaatt cgaaaatcca 1440 acagaaagct taatgttggt ggattctata cagcgactcg gtattgaata ccattttcag 1500 gaagagattg aagcagttct tcggcgacat tacatggaag caccactg tttgatgtg 1560 cactcggatt acactcttca cgatctttca cttttcttca gactcttgag acaacatggt 1620 tttttcattc ccgcagacat attcaacaac ttcaagggaa aagatgggat gtttgaagag 1680 aaattaacgc aagatatcag aggattgatg gaattgtgtg aagctgctca actagtgaca 1740 gaaggagaag atattcttga tgaagcagca aaatttagta gccaatttgt tagtaacaga 1800 ttgaaacatc cttatcacaa aagcattgca agatttactg cgaaaaacta tattagagat 1860 ttccaaggca taaatattgg atgggaaaaa acattgaaag agctcgccaa aatggatttt 1920 tccttggcac agaccgccaa tcaacaagaa cttgcccaaa tttccaagtg gtggaaagac 1980 cttggcttgg ctcaggagtt taagcatgct aggaatcaac ctttaaaatg gtatacatgg 2040 tccatggcct ccctaagtga tccaagcatg tctgagcaaa gacttgagct caccaaatcc 2100 atcacattta tttacataat agatgacatt tttgatcttt atgggacccc agaagacctt 2160 actgtcttta ctcaagctgt acacaggtgg gactatgcag ccgttgacat gttaccaaaa 2220 ccttggaaga tgtgttacaa ggctcttct gacaccacaa atgatatagg cagcaagatc 2280 2340. 2340. 2340. 2340. 2340. 2340. 2340. 2340. 2340. 2340. 2340 gacgcattcc tagtagc taaatggttt gcttcagggc acttgccaac cacccatgag 2460. tacctagaaa atggtaaggt gagttcagga gtacatgtgg tgctcgtcca cctcttcttt cttttggga tcaatggggg gaccgttcag gtggatgata tttcagcact catatcctct gtggctgcta ttctccgtct ctgggatgac tttggaagtg ctaaggatga gcagcaagat ggaaacgatg gttcgtacat agagtgctac atgaaagaaa atccaggatc aaccgttgag attgcacgag atcgtgttgt tgatatgata tcaagtgaat ggaagcggct taacaaggag tgttttcgtt taaatcaaaa tccatcaagt tcatctttca caaaagcttc ttttaatctt gcaagaatgg tccctctaat gtacagttac gatgacaacc aacagctccc agtacttgaa gagtacatca actccacact ctttgatgat aatttcttgg tgcaccatcc agcacaactg atgaagaatg ccacaattcg tgggtcatag
Claims
1. Any of the following applications of protein: P1. Application of the protein in the production of Aquilaria sesquiterpenes, P2. Application of the protein in the preparation and production of agarwood sesquiterpene products; The protein is the following protein: A1) The amino acid sequence is the protein of sequence 1 in the sequence list, A2) The amino acid sequence is the protein of sequence 3 in the sequence list, A3) A fusion protein obtained by fusing a protein tag at the carboxyl or / and amino terminus of the protein shown in A1) or A2); The agarwood sesquiterpenoid is agarwood sesquiterpenoid trans-nerolidol.
2. Use of a protein as an Aquilaria sinensis sesquiterpene trans-nerolidol synthase or in the preparation of trans-nerolidol, wherein the protein is the protein described in claim 1.
3. Any of the following uses of the biological material related to the protein described in claim 1: F1. Application of the biological material in the production of Aquilaria sesquiterpenes, F2. Application of the biomaterial in the preparation and production of Aquilaria sesquiterpenoid products; The biological material is any one of the following D1) to D6): D1) A nucleic acid molecule encoding the protein according to claim 1; D2) an expression cassette containing the nucleic acid molecule described in D1); D3) a recombinant vector containing the nucleic acid molecule described in D1), or a recombinant vector containing the expression cassette described in D2); D4) a recombinant microorganism containing the nucleic acid molecule described in D1), or a recombinant microorganism containing the expression cassette described in D2), or a recombinant microorganism containing the recombinant vector described in D3); The agarwood sesquiterpenoid is agarwood sesquiterpenoid trans-nerolidol.
4. The use according to claim 3, characterized in that: D1) The nucleic acid molecule is a gene encoding the protein as shown below: d1) The coding sequence is a cDNA molecule or a DNA molecule of sequence 2 in the sequence list; d2) The nucleotide is a cDNA molecule or a DNA molecule of sequence 4 in the sequence list.
5. The protein according to claim 1 and / or the biological material according to claim 3 or 4.
6. A method for preparing agarwood sesquiterpenoid trans-nerolidol, comprising the following steps: using the protein described in claim 1 as agarwood sesquiterpenoid trans-nerolidol synthase to catalyze the substrate farnesyl pyrophosphate ammonium salt FPP to obtain the agarwood sesquiterpenoid trans-nerolidol.
7. A method for preparing Aquilaria woodii sesquiterpenoid trans-nerolidol synthase, comprising the following steps: expressing the coding gene of the protein described in claim 1 in a prokaryotic microorganism to obtain the Aquilaria woodii sesquiterpenoid trans-nerolidol synthase.
8. The method according to claim 7, characterized in that: The expression of the coding gene of the protein described in claim 1 in a prokaryotic microorganism comprises introducing the coding gene of the protein described in claim 1 into a recipient microorganism to obtain a recombinant microorganism expressing the Aquilaria aromatica sesquiterpene trans-nerolidol synthase, culturing the recombinant microorganism to express the Aquilaria aromatica sesquiterpene trans-nerolidol synthase.
9. The method according to claim 7 or 8, characterized in that: The expression is induced expression.
